1997-05-12
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy
Publication
Publication
European Journal of Nuclear Medicine , Volume 24 - Issue 4 p. 368- 371
Additional Metadata | |
---|---|
, , , , | |
doi.org/10.1007/s002590050064, hdl.handle.net/1765/64878 | |
European Journal of Nuclear Medicine | |
Organisation | Department of Internal Medicine |
de Jong, M., Bakker, W., Krenning, E., Breeman, W., van der Pluijm, M., Bernard, B., … Mäcke, H. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine, 24(4), 368–371. doi:10.1007/s002590050064 |